Clinical trial
Comparison of Remifentanil-dexmedetomidine and Dexmedetomidine-fentanyl Sedation Protocols for Pregnant Patients Undergoing Minimally Invasive Fetoscopic Procedures
NCT05654064 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Remifentanil-dexmedetomidine and Dexmedetomidine-fentanyl Sedation Protocols for Pregnant Patients Undergoing Minimally Invasive Fetoscopic Procedures
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- April 30, 2022
- Completion date
- April 30, 2024
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
minimally invasive fetoscopic procedures